Cold Chain Products Market for Plasma Fractionation to Grow at a CAGR of 4.63% to 2029
The increasing globalization of supply chains for plasma fractionation products necessitates efficient cold chain logistics to support the distribution of products across regions are the drivers for the Global Cold Chain Products Market for Plasma Fractionation during the forecast period 2025-2029
According to
TechSci Research report, “Cold Chain Products Market for Plasma
Fractionation – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2029F”, the Global Cold Chain Products Market for Plasma Fractionation was valued at USD 581.12 million in 2023 and will see an impressive growth in the
forecast period at a CAGR of 4.63% through 2029. Increased investments in healthcare infrastructure often entail the establishment or expansion of plasma fractionation facilities. These facilities are pivotal for processing plasma collected from donors into various plasma-derived therapies. As the number and capacity of fractionation facilities expand, so does the demand for cold chain products to uphold the integrity and safety of plasma components during processing, storage, and distribution.
Healthcare infrastructure investments may encompass the construction or renovation of storage and distribution facilities for plasma-derived therapies. Cold chain products, such as refrigeration units, temperature monitoring devices, and packaging materials, are indispensable for ensuring the proper storage conditions and secure transportation of plasma products to healthcare facilities and patients. These investments in healthcare infrastructure aim to enhance access to healthcare services, including plasma-derived therapies, for patients across urban and rural areas. Cold chain products play a critical role in facilitating the efficient and timely delivery of plasma products to healthcare facilities, thereby enabling patients to access life-saving treatments promptly as needed.
The biopharmaceutical industry is undergoing rapid expansion, propelled by advancements in biotechnology and escalating investments in research and development. Within this sector, plasma fractionation holds significant importance as it yields therapeutic proteins from plasma. As the biopharmaceutical landscape evolves, there's a parallel surge in the demand for plasma fractionation, necessitating a corresponding increase in cold chain products to ensure the safe storage and transportation of plasma-derived products.
This growth in the biopharmaceutical domain directly drives the need for cold chain products tailored for plasma fractionation. Essential to this process are plasma collection centers, which serve as crucial hubs for sourcing plasma. Globally, there's been a notable uptick in the establishment of plasma collection centers, propelled by factors such as heightened demand for plasma-derived products, technological advancements in collection methods, and incentives for plasma donors. Given their dispersed geographic presence, collected plasma must be transported to fractionation facilities while adhering to specific temperature conditions. The proliferation of plasma collection centers underscores the heightened demand for cold chain products encompassing packaging, storage, and transportation solutions. These products are integral to maintaining the quality and efficacy of collected plasma throughout the logistical journey.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global Cold Chain Products Market for Plasma Fractionation”
Personalized medicine, which aims to customize medical treatment according to an individual's unique characteristics, is gaining traction in healthcare. Plasma-derived products obtained through fractionation are integral to personalized medicine as they are utilized in treating various diseases and conditions. As the field of personalized medicine progresses and more targeted therapies are developed, the demand for plasma-derived products is expected to surge. This uptick in demand will necessitate effective cold chain products to ensure the safe storage and transportation of these temperature-sensitive products.
The global prevalence of chronic diseases, such as autoimmune disorders, bleeding disorders, and primary immunodeficiency, continues to escalate. Plasma-derived products derived from fractionation are indispensable for treating these conditions. As the number of patients requiring plasma-derived products grows, there will be a corresponding rise in the demand for cold chain products for plasma fractionation. The market will experience growth as manufacturers and distributors seek reliable and efficient cold chain solutions to cater to the increasing demand for plasma-derived products.
The Global Cold
Chain Products Market for Plasma Fractionation is segmented into Type, End User,
regional distribution, and company.
Based on its Type,
Global Cold Chain Products Market for Plasma Fractionation is segmented into Ultra-low
temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma
contact shock freezer, Blood transport boxes, Ice-lined refrigerator, Others.
An
ultra-low temperature freezer is a specialized piece of equipment used in the
cold chain industry to store temperature-sensitive products, including
biological samples, vaccines, plasma-derived products, and other
pharmaceuticals, at extremely low temperatures. These freezers are designed to
maintain temperatures significantly below freezing, typically ranging from
-40°C to as low as -86°C or even lower. Ultra-low temperature freezers are equipped with
powerful refrigeration systems capable of achieving and maintaining
temperatures well below freezing. Advanced temperature control mechanisms
ensure precise temperature regulation to prevent fluctuations and maintain
consistent storage conditions for sensitive products. Ultra-low temperature
freezers feature high-quality insulation materials and robust sealing
mechanisms to minimize heat transfer and maintain stable temperature conditions
inside the storage chamber. This helps prevent temperature fluctuations and
ensures uniform cooling throughout the freezer.
Based on region,
North America is dominating the market. North America exhibits significant demand for plasma-derived therapies, driven by prevalent conditions such as immune deficiencies, hemophilia, and neurological disorders. The region's aging demographic and rising incidence of chronic diseases further bolster the need for plasma fractionation products. North American firms consistently invest in expanding their plasma fractionation facilities, enhancing cold chain capabilities, and establishing strategic partnerships to fortify their global market position. These investments enable North American entities to meet the escalating demand for plasma-derived therapies while sustaining their competitive advantage.
North America benefits from access to a skilled workforce, prominent research institutions, and robust resources dedicated to the biopharmaceutical sector. This conducive environment fosters innovation, research, and development, leading to advancements in plasma fractionation technology and cold chain management practices.
Major companies
operating in Global Cold Chain Products Market for Plasma Fractionation
are:
- B Medical Systems Sàrl
- Blue Star Limited
- Thermo Fisher Scientific Inc.
- Godrej and Boyce Manufacturing
Co. Ltd.
- Haier Biomedical
- Eppendorf SE
- Avantor, Inc.
- Biolife Solutions Inc.
- Helmer Scientific Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Cold Chain
Products Market for Plasma Fractionation is witnessing swift expansion, marked
by technological advancements and an intensified emphasis on regulatory
adherence and patient safety. With the escalating demand for plasma-derived
therapies, players within the plasma fractionation sector must persist in
investing in cutting-edge cold chain solutions while maintaining strict quality
standards. This commitment is crucial to safeguarding the reliability and
effectiveness of plasma products across the entire supply chain.," said
Mr. Karan Chechi, Research Director of TechSci Research, a research-based
Global management consulting firm.
“Cold Chain Products Market for Plasma Fractionation - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, Others), By End User (Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, Others), By Region, and By Competition, 2019-2029F”, has evaluated the future growth
potential of Global Cold Chain Products Market for Plasma Fractionation and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cold Chain Products Market for Plasma
Fractionation.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com